ID   FIBG_RAT                Reviewed;         445 AA.
AC   P02680; Q68FY3;
DT   21-JUL-1986, integrated into UniProtKB/Swiss-Prot.
DT   09-JAN-2007, sequence version 3.
DT   29-MAY-2024, entry version 171.
DE   RecName: Full=Fibrinogen gamma chain;
DE   Flags: Precursor;
GN   Name=Fgg;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORMS GAMMA-B AND GAMMA-A).
RX   PubMed=6897622; DOI=10.1016/0092-8674(82)90415-9;
RA   Crabtree G.R., Kant J.A.;
RT   "Organization of the rat gamma-fibrinogen gene: alternative mRNA splice
RT   patterns produce the gamma A and gamma B (gamma ') chains of fibrinogen.";
RL   Cell 31:159-166(1982).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=3562236; DOI=10.1093/nar/15.6.2774;
RA   Morgan J.G., Holbrook N.J., Crabtree G.R.;
RT   "Nucleotide sequence of the gamma chain gene of rat fibrinogen: conserved
RT   intronic sequences.";
RL   Nucleic Acids Res. 15:2774-2776(1987).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM GAMMA-A).
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-102.
RX   PubMed=6232608; DOI=10.1073/pnas.81.8.2313;
RA   Fowlkes D.M., Mullis N.T., Comeau C.M., Crabtree G.R.;
RT   "Potential basis for regulation of the coordinately expressed fibrinogen
RT   genes: homology in the 5' flanking regions.";
RL   Proc. Natl. Acad. Sci. U.S.A. 81:2313-2316(1984).
RN   [5]
RP   PROTEIN SEQUENCE OF 122-134, AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   STRAIN=Sprague-Dawley; TISSUE=Spinal cord;
RA   Lubec G., Afjehi-Sadat L.;
RL   Submitted (NOV-2006) to UniProtKB.
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-431, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Together with fibrinogen alpha (FGA) and fibrinogen beta
CC       (FGB), polymerizes to form an insoluble fibrin matrix. Has a major
CC       function in hemostasis as one of the primary components of blood clots.
CC       In addition, functions during the early stages of wound repair to
CC       stabilize the lesion and guide cell migration during re-
CC       epithelialization. Was originally thought to be essential for platelet
CC       aggregation, based on in vitro studies using anticoagulated blood.
CC       However, subsequent studies have shown that it is not absolutely
CC       required for thrombus formation in vivo. Enhances expression of SELP in
CC       activated platelets via an ITGB3-dependent pathway. Maternal fibrinogen
CC       is essential for successful pregnancy. Fibrin deposition is also
CC       associated with infection, where it protects against IFNG-mediated
CC       hemorrhage. May also facilitate the antibacterial immune response via
CC       both innate and T-cell mediated pathways.
CC       {ECO:0000250|UniProtKB:E9PV24}.
CC   -!- SUBUNIT: Heterohexamer; disulfide linked. Contains 2 sets of 3 non-
CC       identical chains (alpha, beta and gamma). The 2 heterotrimers are in
CC       head to head conformation with the N-termini in a small central domain
CC       (By similarity). {ECO:0000250|UniProtKB:P02679}.
CC   -!- SUBCELLULAR LOCATION: Secreted {ECO:0000250|UniProtKB:P02679}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=Gamma-B;
CC         IsoId=P02680-1; Sequence=Displayed;
CC       Name=Gamma-A;
CC         IsoId=P02680-2; Sequence=VSP_001538, VSP_001539;
CC   -!- DOMAIN: A long coiled coil structure formed by 3 polypeptide chains
CC       connects the central nodule to the C-terminal domains (distal nodules).
CC       The long C-terminal ends of the alpha chains fold back, contributing a
CC       fourth strand to the coiled coil structure.
CC       {ECO:0000250|UniProtKB:P02679}.
CC   -!- PTM: Conversion of fibrinogen to fibrin is triggered by thrombin, which
CC       cleaves fibrinopeptides A and B from alpha and beta chains, and thus
CC       exposes the N-terminal polymerization sites responsible for the
CC       formation of the soft clot. The soft clot is converted into the hard
CC       clot by factor XIIIA which catalyzes the epsilon-(gamma-glutamyl)lysine
CC       cross-linking between gamma chains (stronger) and between alpha chains
CC       (weaker) of different monomers.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; J00733; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; J00734; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; J00735; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; X05860; CAA29289.1; -; Genomic_DNA.
DR   EMBL; X05861; CAA29289.1; JOINED; Genomic_DNA.
DR   EMBL; BC078893; AAH78893.1; -; mRNA.
DR   EMBL; K01337; AAA98626.1; -; Genomic_DNA.
DR   PIR; A03128; FGRTGB.
DR   PIR; A90828; FGRTGA.
DR   RefSeq; NP_036691.2; NM_012559.2. [P02680-2]
DR   RefSeq; XP_006232587.1; XM_006232525.1. [P02680-1]
DR   AlphaFoldDB; P02680; -.
DR   SMR; P02680; -.
DR   BioGRID; 246539; 1.
DR   IntAct; P02680; 2.
DR   STRING; 10116.ENSRNOP00000032735; -.
DR   GlyCosmos; P02680; 1 site, No reported glycans.
DR   GlyGen; P02680; 2 sites, 1 O-linked glycan (1 site).
DR   iPTMnet; P02680; -.
DR   PhosphoSitePlus; P02680; -.
DR   PaxDb; 10116-ENSRNOP00000032735; -.
DR   Ensembl; ENSRNOT00000034521.7; ENSRNOP00000032735.4; ENSRNOG00000025074.7. [P02680-2]
DR   Ensembl; ENSRNOT00000115976.1; ENSRNOP00000082495.1; ENSRNOG00000025074.7. [P02680-1]
DR   Ensembl; ENSRNOT00055037761; ENSRNOP00055030804; ENSRNOG00055021991. [P02680-1]
DR   Ensembl; ENSRNOT00060012122; ENSRNOP00060009138; ENSRNOG00060007361. [P02680-1]
DR   Ensembl; ENSRNOT00065053321; ENSRNOP00065043814; ENSRNOG00065030932. [P02680-1]
DR   GeneID; 24367; -.
DR   KEGG; rno:24367; -.
DR   UCSC; RGD:2613; rat. [P02680-1]
DR   AGR; RGD:2613; -.
DR   CTD; 2266; -.
DR   RGD; 2613; Fgg.
DR   eggNOG; KOG2579; Eukaryota.
DR   GeneTree; ENSGT00940000158467; -.
DR   HOGENOM; CLU_038628_13_0_1; -.
DR   InParanoid; P02680; -.
DR   OMA; TYHNGMR; -.
DR   OrthoDB; 3134470at2759; -.
DR   PhylomeDB; P02680; -.
DR   TreeFam; TF336658; -.
DR   Reactome; R-RNO-114608; Platelet degranulation.
DR   Reactome; R-RNO-140875; Common Pathway of Fibrin Clot Formation.
DR   Reactome; R-RNO-216083; Integrin cell surface interactions.
DR   Reactome; R-RNO-354192; Integrin signaling.
DR   Reactome; R-RNO-354194; GRB2:SOS provides linkage to MAPK signaling for Integrins.
DR   Reactome; R-RNO-372708; p130Cas linkage to MAPK signaling for integrins.
DR   Reactome; R-RNO-381426; Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs).
DR   Reactome; R-RNO-5674135; MAP2K and MAPK activation.
DR   Reactome; R-RNO-5686938; Regulation of TLR by endogenous ligand.
DR   Reactome; R-RNO-8957275; Post-translational protein phosphorylation.
DR   PRO; PR:P02680; -.
DR   Proteomes; UP000002494; Chromosome 2.
DR   Bgee; ENSRNOG00000025074; Expressed in liver and 18 other cell types or tissues.
DR   GO; GO:0072562; C:blood microparticle; IDA:RGD.
DR   GO; GO:0005938; C:cell cortex; ISO:RGD.
DR   GO; GO:0009986; C:cell surface; ISO:RGD.
DR   GO; GO:0062023; C:collagen-containing extracellular matrix; IBA:GO_Central.
DR   GO; GO:0009897; C:external side of plasma membrane; ISO:RGD.
DR   GO; GO:0005615; C:extracellular space; ISO:RGD.
DR   GO; GO:0005577; C:fibrinogen complex; ISO:RGD.
DR   GO; GO:0031091; C:platelet alpha granule; ISO:RGD.
DR   GO; GO:0045202; C:synapse; ISO:RGD.
DR   GO; GO:0050839; F:cell adhesion molecule binding; ISO:RGD.
DR   GO; GO:0042802; F:identical protein binding; IPI:RGD.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0005102; F:signaling receptor binding; ISO:RGD.
DR   GO; GO:0005198; F:structural molecule activity; ISO:RGD.
DR   GO; GO:0072378; P:blood coagulation, fibrin clot formation; ISO:RGD.
DR   GO; GO:0007160; P:cell-matrix adhesion; ISO:RGD.
DR   GO; GO:0071347; P:cellular response to interleukin-1; IEP:RGD.
DR   GO; GO:0071354; P:cellular response to interleukin-6; IEP:RGD.
DR   GO; GO:0042730; P:fibrinolysis; ISO:RGD.
DR   GO; GO:2000352; P:negative regulation of endothelial cell apoptotic process; ISO:RGD.
DR   GO; GO:1902042; P:negative regulation of extrinsic apoptotic signaling pathway via death domain receptors; ISO:RGD.
DR   GO; GO:0031639; P:plasminogen activation; ISO:RGD.
DR   GO; GO:0070527; P:platelet aggregation; ISO:RGD.
DR   GO; GO:0036345; P:platelet maturation; IEP:RGD.
DR   GO; GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; ISO:RGD.
DR   GO; GO:0045921; P:positive regulation of exocytosis; ISO:RGD.
DR   GO; GO:0034116; P:positive regulation of heterotypic cell-cell adhesion; ISO:RGD.
DR   GO; GO:0090277; P:positive regulation of peptide hormone secretion; ISO:RGD.
DR   GO; GO:0050714; P:positive regulation of protein secretion; ISO:RGD.
DR   GO; GO:0045907; P:positive regulation of vasoconstriction; ISO:RGD.
DR   GO; GO:0051258; P:protein polymerization; ISO:RGD.
DR   GO; GO:0009306; P:protein secretion; ISO:RGD.
DR   GO; GO:0065003; P:protein-containing complex assembly; ISO:RGD.
DR   GO; GO:0051592; P:response to calcium ion; ISO:RGD.
DR   CDD; cd00087; FReD; 1.
DR   Gene3D; 1.20.5.50; -; 2.
DR   Gene3D; 3.90.215.10; Gamma Fibrinogen, chain A, domain 1; 1.
DR   Gene3D; 4.10.530.10; Gamma-fibrinogen Carboxyl Terminal Fragment, domain 2; 1.
DR   InterPro; IPR037579; Fibrinogen.
DR   InterPro; IPR036056; Fibrinogen-like_C.
DR   InterPro; IPR014716; Fibrinogen_a/b/g_C_1.
DR   InterPro; IPR002181; Fibrinogen_a/b/g_C_dom.
DR   InterPro; IPR012290; Fibrinogen_a/b/g_coil_dom.
DR   InterPro; IPR020837; Fibrinogen_CS.
DR   PANTHER; PTHR47221; FIBRINOGEN ALPHA CHAIN; 1.
DR   PANTHER; PTHR47221:SF4; FIBRINOGEN GAMMA CHAIN; 1.
DR   Pfam; PF08702; Fib_alpha; 1.
DR   Pfam; PF00147; Fibrinogen_C; 1.
DR   SMART; SM00186; FBG; 1.
DR   SMART; SM01212; Fib_alpha; 1.
DR   SUPFAM; SSF56496; Fibrinogen C-terminal domain-like; 1.
DR   SUPFAM; SSF58010; Fibrinogen coiled-coil and central regions; 1.
DR   PROSITE; PS00514; FIBRINOGEN_C_1; 1.
DR   PROSITE; PS51406; FIBRINOGEN_C_2; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Blood coagulation; Calcium; Coiled coil;
KW   Direct protein sequencing; Disulfide bond; Glycoprotein; Hemostasis;
KW   Isopeptide bond; Metal-binding; Phosphoprotein; Reference proteome;
KW   Secreted; Signal.
FT   SIGNAL          1..25
FT   CHAIN           26..445
FT                   /note="Fibrinogen gamma chain"
FT                   /id="PRO_0000009101"
FT   DOMAIN          170..416
FT                   /note="Fibrinogen C-terminal"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00739"
FT   REGION          400..422
FT                   /note="Gamma-chain polymerization, binding amino end of
FT                   another fibrin alpha chain"
FT                   /evidence="ECO:0000250"
FT   REGION          424..445
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         344
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000250|UniProtKB:P04115"
FT   BINDING         346
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000250|UniProtKB:P04115"
FT   BINDING         350
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000250|UniProtKB:P04115"
FT   MOD_RES         431
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   CARBOHYD        78
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        34
FT                   /note="Interchain (with gamma chain)"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00739"
FT   DISULFID        35
FT                   /note="Interchain (with gamma chain)"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00739"
FT   DISULFID        45
FT                   /note="Interchain (with beta chain)"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00739"
FT   DISULFID        49
FT                   /note="Interchain (with alpha chain)"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00739"
FT   DISULFID        161
FT                   /note="Interchain (with beta chain)"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00739"
FT   DISULFID        165
FT                   /note="Interchain (with gamma chain)"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00739"
FT   DISULFID        179..208
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00739"
FT   DISULFID        352..365
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00739"
FT   CROSSLNK        424
FT                   /note="Isoglutamyl lysine isopeptide (Gln-Lys) (interchain
FT                   with K-432)"
FT                   /evidence="ECO:0000250"
FT   CROSSLNK        432
FT                   /note="Isoglutamyl lysine isopeptide (Lys-Gln) (interchain
FT                   with Q-424)"
FT                   /evidence="ECO:0000250"
FT   VAR_SEQ         435..437
FT                   /note="SVE -> GDM (in isoform Gamma-A)"
FT                   /evidence="ECO:0000303|PubMed:15489334,
FT                   ECO:0000303|PubMed:6897622"
FT                   /id="VSP_001538"
FT   VAR_SEQ         438..445
FT                   /note="Missing (in isoform Gamma-A)"
FT                   /evidence="ECO:0000303|PubMed:15489334,
FT                   ECO:0000303|PubMed:6897622"
FT                   /id="VSP_001539"
FT   CONFLICT        160
FT                   /note="Q -> L (in Ref. 1; J00734 and 2; CAA29289)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        162
FT                   /note="Q -> K (in Ref. 1; J00734)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        172..174
FT                   /note="HDT -> YDI (in Ref. 1; J00734 and 2; CAA29289)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        182
FT                   /note="I -> T (in Ref. 1; J00734 and 2; CAA29289)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        194
FT                   /note="F -> S (in Ref. 1; J00734 and 2; CAA29289)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        202
FT                   /note="Q -> E (in Ref. 1; J00734 and 2; CAA29289)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        204
FT                   /note="F -> S (in Ref. 1; J00734)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        210
FT                   /note="I -> T (in Ref. 1; J00734 and 2; CAA29289)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        213
FT                   /note="S -> P (in Ref. 1; J00734 and 2; CAA29289)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        219..221
FT                   /note="VLQ -> EFK (in Ref. 1; J00734 and 2; CAA29289)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        231
FT                   /note="K -> L (in Ref. 1; J00734 and 2; CAA29289)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        259
FT                   /note="I -> N (in Ref. 1; J00734 and 2; CAA29289)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        296
FT                   /note="E -> G (in Ref. 1; J00734)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        373
FT                   /note="V -> G (in Ref. 1; J00735)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        401
FT                   /note="R -> S (in Ref. 1; J00735)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   445 AA;  50633 MW;  EB6F4FF7A7812054 CRC64;
     MNWSLQLRSF ILCWALLLLS PTGLAQYTAT RDNCCILDER FGSYCPTTCG ISDFLNSYQT
     DVDTDLQTLE NILQRAENRT TEAKELIKAI QVYYNPDQPP KPGMIEGATQ KSKKMVEEIL
     KYEALLLTHE SSIRYLQDIY TSNKQKITNL KQKVAQLEAQ CQEPCKDSVR IHDTTGKDCQ
     DIANKGAKES GLYFIRPLKA TQQFLVYCEI DGSGNGWTVL QKRLDGSVDF KKNWIQYKEG
     FGHLSPTGTT EFWLGNEKIH LISMQSTIPY ALRIQLKDWS GRTSTADYAM FRVGPESDKY
     RLTYAYFIGG DAGDAFDGYD FGDDPSDKFF TSHNGMHFST WDNDNDKFEG NCAEQDGSGW
     WMNKCHAGHL NGVYYQGGTY SKSSTPNGYD NGIIWATWKT RWYSMKETTM KIIPFNRLSI
     GDGQQHHMGG SKQVSVEHEV DVEYP
//
